nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymorphone—Morphine—UGT2B7—urinary bladder cancer	0.0159	0.719	CrCbGaD
Oxymorphone—Naloxone—ESR1—urinary bladder cancer	0.00622	0.281	CrCbGaD
Oxymorphone—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00181	0.00186	CcSEcCtD
Oxymorphone—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00181	0.00185	CcSEcCtD
Oxymorphone—Somnolence—Fluorouracil—urinary bladder cancer	0.00181	0.00185	CcSEcCtD
Oxymorphone—Hypotension—Cisplatin—urinary bladder cancer	0.0018	0.00184	CcSEcCtD
Oxymorphone—Decreased appetite—Gemcitabine—urinary bladder cancer	0.0018	0.00184	CcSEcCtD
Oxymorphone—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00179	0.00183	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00179	0.00183	CcSEcCtD
Oxymorphone—Fatigue—Gemcitabine—urinary bladder cancer	0.00179	0.00183	CcSEcCtD
Oxymorphone—Confusional state—Etoposide—urinary bladder cancer	0.00178	0.00182	CcSEcCtD
Oxymorphone—Pain—Gemcitabine—urinary bladder cancer	0.00177	0.00181	CcSEcCtD
Oxymorphone—Constipation—Gemcitabine—urinary bladder cancer	0.00177	0.00181	CcSEcCtD
Oxymorphone—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00177	0.00181	CcSEcCtD
Oxymorphone—Asthenia—Thiotepa—urinary bladder cancer	0.00177	0.00181	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00176	0.0018	CcSEcCtD
Oxymorphone—Abdominal distension—Epirubicin—urinary bladder cancer	0.00175	0.00179	CcSEcCtD
Oxymorphone—Pruritus—Thiotepa—urinary bladder cancer	0.00174	0.00178	CcSEcCtD
Oxymorphone—Pain—Fluorouracil—urinary bladder cancer	0.00174	0.00178	CcSEcCtD
Oxymorphone—Dehydration—Doxorubicin—urinary bladder cancer	0.00174	0.00177	CcSEcCtD
Oxymorphone—Tachycardia—Etoposide—urinary bladder cancer	0.00173	0.00176	CcSEcCtD
Oxymorphone—Dyspnoea—Cisplatin—urinary bladder cancer	0.00172	0.00176	CcSEcCtD
Oxymorphone—Skin disorder—Etoposide—urinary bladder cancer	0.00172	0.00176	CcSEcCtD
Oxymorphone—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00171	0.00175	CcSEcCtD
Oxymorphone—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00171	0.00174	CcSEcCtD
Oxymorphone—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	0.0017	0.00174	CcSEcCtD
Oxymorphone—Anorexia—Etoposide—urinary bladder cancer	0.00169	0.00172	CcSEcCtD
Oxymorphone—Diarrhoea—Thiotepa—urinary bladder cancer	0.00168	0.00172	CcSEcCtD
Oxymorphone—Decreased appetite—Cisplatin—urinary bladder cancer	0.00168	0.00172	CcSEcCtD
Oxymorphone—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00168	0.00172	CcSEcCtD
Oxymorphone—Pneumonia—Methotrexate—urinary bladder cancer	0.00167	0.00171	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00167	0.0017	CcSEcCtD
Oxymorphone—Hypotension—Etoposide—urinary bladder cancer	0.00165	0.00169	CcSEcCtD
Oxymorphone—Pain—Cisplatin—urinary bladder cancer	0.00165	0.00169	CcSEcCtD
Oxymorphone—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00164	0.00167	CcSEcCtD
Oxymorphone—Dizziness—Thiotepa—urinary bladder cancer	0.00163	0.00166	CcSEcCtD
Oxymorphone—Abdominal distension—Doxorubicin—urinary bladder cancer	0.00162	0.00166	CcSEcCtD
Oxymorphone—Urticaria—Fluorouracil—urinary bladder cancer	0.00162	0.00165	CcSEcCtD
Oxymorphone—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00161	0.00165	CcSEcCtD
Oxymorphone—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00159	0.00163	CcSEcCtD
Oxymorphone—Weight decreased—Epirubicin—urinary bladder cancer	0.00158	0.00161	CcSEcCtD
Oxymorphone—Dyspnoea—Etoposide—urinary bladder cancer	0.00158	0.00161	CcSEcCtD
Oxymorphone—Somnolence—Etoposide—urinary bladder cancer	0.00157	0.00161	CcSEcCtD
Oxymorphone—Vomiting—Thiotepa—urinary bladder cancer	0.00156	0.0016	CcSEcCtD
Oxymorphone—Pneumonia—Epirubicin—urinary bladder cancer	0.00156	0.0016	CcSEcCtD
Oxymorphone—Dermatitis—Thiotepa—urinary bladder cancer	0.00155	0.00159	CcSEcCtD
Oxymorphone—Headache—Thiotepa—urinary bladder cancer	0.00154	0.00158	CcSEcCtD
Oxymorphone—Decreased appetite—Etoposide—urinary bladder cancer	0.00154	0.00157	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00153	0.00156	CcSEcCtD
Oxymorphone—Body temperature increased—Cisplatin—urinary bladder cancer	0.00153	0.00156	CcSEcCtD
Oxymorphone—Fatigue—Etoposide—urinary bladder cancer	0.00152	0.00156	CcSEcCtD
Oxymorphone—Constipation—Etoposide—urinary bladder cancer	0.00151	0.00155	CcSEcCtD
Oxymorphone—Pain—Etoposide—urinary bladder cancer	0.00151	0.00155	CcSEcCtD
Oxymorphone—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.0015	0.00153	CcSEcCtD
Oxymorphone—Asthenia—Gemcitabine—urinary bladder cancer	0.00149	0.00152	CcSEcCtD
Oxymorphone—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.00147	0.00151	CcSEcCtD
Oxymorphone—Pruritus—Gemcitabine—urinary bladder cancer	0.00146	0.0015	CcSEcCtD
Oxymorphone—Nausea—Thiotepa—urinary bladder cancer	0.00146	0.0015	CcSEcCtD
Oxymorphone—Urethral disorder—Methotrexate—urinary bladder cancer	0.00146	0.00149	CcSEcCtD
Oxymorphone—Weight decreased—Doxorubicin—urinary bladder cancer	0.00146	0.00149	CcSEcCtD
Oxymorphone—Feeling abnormal—Etoposide—urinary bladder cancer	0.00146	0.00149	CcSEcCtD
Oxymorphone—Pneumonia—Doxorubicin—urinary bladder cancer	0.00145	0.00148	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00145	0.00148	CcSEcCtD
Oxymorphone—Pruritus—Fluorouracil—urinary bladder cancer	0.00144	0.00147	CcSEcCtD
Oxymorphone—Visual impairment—Methotrexate—urinary bladder cancer	0.00144	0.00147	CcSEcCtD
Oxymorphone—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00142	0.00145	CcSEcCtD
Oxymorphone—Bradycardia—Epirubicin—urinary bladder cancer	0.00142	0.00145	CcSEcCtD
Oxymorphone—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00142	0.00145	CcSEcCtD
Oxymorphone—Urticaria—Etoposide—urinary bladder cancer	0.0014	0.00144	CcSEcCtD
Oxymorphone—Abdominal pain—Etoposide—urinary bladder cancer	0.0014	0.00143	CcSEcCtD
Oxymorphone—Body temperature increased—Etoposide—urinary bladder cancer	0.0014	0.00143	CcSEcCtD
Oxymorphone—Eye disorder—Methotrexate—urinary bladder cancer	0.00139	0.00142	CcSEcCtD
Oxymorphone—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00139	0.00142	CcSEcCtD
Oxymorphone—Asthenia—Cisplatin—urinary bladder cancer	0.00138	0.00142	CcSEcCtD
Oxymorphone—Cardiac disorder—Methotrexate—urinary bladder cancer	0.00138	0.00141	CcSEcCtD
Oxymorphone—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.00138	0.00141	CcSEcCtD
Oxymorphone—Urethral disorder—Epirubicin—urinary bladder cancer	0.00137	0.0014	CcSEcCtD
Oxymorphone—Angiopathy—Methotrexate—urinary bladder cancer	0.00135	0.00138	CcSEcCtD
Oxymorphone—Immune system disorder—Methotrexate—urinary bladder cancer	0.00135	0.00138	CcSEcCtD
Oxymorphone—Dizziness—Fluorouracil—urinary bladder cancer	0.00135	0.00138	CcSEcCtD
Oxymorphone—Visual impairment—Epirubicin—urinary bladder cancer	0.00134	0.00137	CcSEcCtD
Oxymorphone—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.00134	0.00137	CcSEcCtD
Oxymorphone—Diarrhoea—Cisplatin—urinary bladder cancer	0.00132	0.00135	CcSEcCtD
Oxymorphone—Vomiting—Gemcitabine—urinary bladder cancer	0.00132	0.00135	CcSEcCtD
Oxymorphone—Bradycardia—Doxorubicin—urinary bladder cancer	0.00131	0.00134	CcSEcCtD
Oxymorphone—Mental disorder—Methotrexate—urinary bladder cancer	0.00131	0.00134	CcSEcCtD
Oxymorphone—Dermatitis—Gemcitabine—urinary bladder cancer	0.0013	0.00133	CcSEcCtD
Oxymorphone—Eye disorder—Epirubicin—urinary bladder cancer	0.0013	0.00133	CcSEcCtD
Oxymorphone—Hypersensitivity—Etoposide—urinary bladder cancer	0.0013	0.00133	CcSEcCtD
Oxymorphone—Malnutrition—Methotrexate—urinary bladder cancer	0.0013	0.00133	CcSEcCtD
Oxymorphone—Headache—Gemcitabine—urinary bladder cancer	0.0013	0.00133	CcSEcCtD
Oxymorphone—Flushing—Epirubicin—urinary bladder cancer	0.00129	0.00132	CcSEcCtD
Oxymorphone—Cardiac disorder—Epirubicin—urinary bladder cancer	0.00129	0.00132	CcSEcCtD
Oxymorphone—Vomiting—Fluorouracil—urinary bladder cancer	0.00129	0.00132	CcSEcCtD
Oxymorphone—Dermatitis—Fluorouracil—urinary bladder cancer	0.00128	0.00131	CcSEcCtD
Oxymorphone—Headache—Fluorouracil—urinary bladder cancer	0.00128	0.0013	CcSEcCtD
Oxymorphone—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.00127	0.0013	CcSEcCtD
Oxymorphone—Asthenia—Etoposide—urinary bladder cancer	0.00127	0.0013	CcSEcCtD
Oxymorphone—Angiopathy—Epirubicin—urinary bladder cancer	0.00127	0.00129	CcSEcCtD
Oxymorphone—Urethral disorder—Doxorubicin—urinary bladder cancer	0.00127	0.00129	CcSEcCtD
Oxymorphone—Immune system disorder—Epirubicin—urinary bladder cancer	0.00126	0.00129	CcSEcCtD
Oxymorphone—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.00126	0.00129	CcSEcCtD
Oxymorphone—Pruritus—Etoposide—urinary bladder cancer	0.00125	0.00128	CcSEcCtD
Oxymorphone—Visual impairment—Doxorubicin—urinary bladder cancer	0.00124	0.00127	CcSEcCtD
Oxymorphone—Nausea—Gemcitabine—urinary bladder cancer	0.00123	0.00126	CcSEcCtD
Oxymorphone—Vomiting—Cisplatin—urinary bladder cancer	0.00123	0.00125	CcSEcCtD
Oxymorphone—Vision blurred—Methotrexate—urinary bladder cancer	0.00122	0.00125	CcSEcCtD
Oxymorphone—Mental disorder—Epirubicin—urinary bladder cancer	0.00122	0.00125	CcSEcCtD
Oxymorphone—Dermatitis—Cisplatin—urinary bladder cancer	0.00122	0.00124	CcSEcCtD
Oxymorphone—Malnutrition—Epirubicin—urinary bladder cancer	0.00121	0.00124	CcSEcCtD
Oxymorphone—Diarrhoea—Etoposide—urinary bladder cancer	0.00121	0.00124	CcSEcCtD
Oxymorphone—Nausea—Fluorouracil—urinary bladder cancer	0.00121	0.00124	CcSEcCtD
Oxymorphone—Eye disorder—Doxorubicin—urinary bladder cancer	0.00121	0.00123	CcSEcCtD
Oxymorphone—Flushing—Doxorubicin—urinary bladder cancer	0.0012	0.00123	CcSEcCtD
Oxymorphone—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.0012	0.00123	CcSEcCtD
Oxymorphone—Flatulence—Epirubicin—urinary bladder cancer	0.0012	0.00122	CcSEcCtD
Oxymorphone—Tension—Epirubicin—urinary bladder cancer	0.00119	0.00122	CcSEcCtD
Oxymorphone—Nervousness—Epirubicin—urinary bladder cancer	0.00118	0.00121	CcSEcCtD
Oxymorphone—Angiopathy—Doxorubicin—urinary bladder cancer	0.00117	0.0012	CcSEcCtD
Oxymorphone—Dizziness—Etoposide—urinary bladder cancer	0.00117	0.0012	CcSEcCtD
Oxymorphone—Immune system disorder—Doxorubicin—urinary bladder cancer	0.00117	0.00119	CcSEcCtD
Oxymorphone—Vertigo—Methotrexate—urinary bladder cancer	0.00117	0.00119	CcSEcCtD
Oxymorphone—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.00116	0.00119	CcSEcCtD
Oxymorphone—Nausea—Cisplatin—urinary bladder cancer	0.00115	0.00117	CcSEcCtD
Oxymorphone—Vision blurred—Epirubicin—urinary bladder cancer	0.00114	0.00117	CcSEcCtD
Oxymorphone—Mental disorder—Doxorubicin—urinary bladder cancer	0.00113	0.00116	CcSEcCtD
Oxymorphone—Convulsion—Methotrexate—urinary bladder cancer	0.00112	0.00115	CcSEcCtD
Oxymorphone—Vomiting—Etoposide—urinary bladder cancer	0.00112	0.00115	CcSEcCtD
Oxymorphone—Malnutrition—Doxorubicin—urinary bladder cancer	0.00112	0.00115	CcSEcCtD
Oxymorphone—Agitation—Epirubicin—urinary bladder cancer	0.00112	0.00114	CcSEcCtD
Oxymorphone—Dermatitis—Etoposide—urinary bladder cancer	0.00111	0.00114	CcSEcCtD
Oxymorphone—Headache—Etoposide—urinary bladder cancer	0.00111	0.00113	CcSEcCtD
Oxymorphone—Flatulence—Doxorubicin—urinary bladder cancer	0.00111	0.00113	CcSEcCtD
Oxymorphone—Chest pain—Methotrexate—urinary bladder cancer	0.0011	0.00113	CcSEcCtD
Oxymorphone—Tension—Doxorubicin—urinary bladder cancer	0.0011	0.00113	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.0011	0.00112	CcSEcCtD
Oxymorphone—Nervousness—Doxorubicin—urinary bladder cancer	0.00109	0.00112	CcSEcCtD
Oxymorphone—Vertigo—Epirubicin—urinary bladder cancer	0.00109	0.00112	CcSEcCtD
Oxymorphone—Syncope—Epirubicin—urinary bladder cancer	0.00109	0.00111	CcSEcCtD
Oxymorphone—Palpitations—Epirubicin—urinary bladder cancer	0.00107	0.0011	CcSEcCtD
Oxymorphone—Confusional state—Methotrexate—urinary bladder cancer	0.00107	0.00109	CcSEcCtD
Oxymorphone—Loss of consciousness—Epirubicin—urinary bladder cancer	0.00107	0.00109	CcSEcCtD
Oxymorphone—Vision blurred—Doxorubicin—urinary bladder cancer	0.00106	0.00108	CcSEcCtD
Oxymorphone—Convulsion—Epirubicin—urinary bladder cancer	0.00105	0.00108	CcSEcCtD
Oxymorphone—Nausea—Etoposide—urinary bladder cancer	0.00105	0.00107	CcSEcCtD
Oxymorphone—Hypertension—Epirubicin—urinary bladder cancer	0.00105	0.00107	CcSEcCtD
Oxymorphone—Nervous system disorder—Methotrexate—urinary bladder cancer	0.00104	0.00106	CcSEcCtD
Oxymorphone—Chest pain—Epirubicin—urinary bladder cancer	0.00103	0.00106	CcSEcCtD
Oxymorphone—Agitation—Doxorubicin—urinary bladder cancer	0.00103	0.00106	CcSEcCtD
Oxymorphone—Anxiety—Epirubicin—urinary bladder cancer	0.00103	0.00105	CcSEcCtD
Oxymorphone—Skin disorder—Methotrexate—urinary bladder cancer	0.00103	0.00105	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.00103	0.00105	CcSEcCtD
Oxymorphone—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.00102	0.00105	CcSEcCtD
Oxymorphone—Dry mouth—Epirubicin—urinary bladder cancer	0.00101	0.00103	CcSEcCtD
Oxymorphone—Vertigo—Doxorubicin—urinary bladder cancer	0.00101	0.00103	CcSEcCtD
Oxymorphone—Anorexia—Methotrexate—urinary bladder cancer	0.00101	0.00103	CcSEcCtD
Oxymorphone—Syncope—Doxorubicin—urinary bladder cancer	0.00101	0.00103	CcSEcCtD
Oxymorphone—Confusional state—Epirubicin—urinary bladder cancer	0.000999	0.00102	CcSEcCtD
Oxymorphone—Palpitations—Doxorubicin—urinary bladder cancer	0.000993	0.00102	CcSEcCtD
Oxymorphone—Oedema—Epirubicin—urinary bladder cancer	0.000991	0.00101	CcSEcCtD
Oxymorphone—Hypotension—Methotrexate—urinary bladder cancer	0.00099	0.00101	CcSEcCtD
Oxymorphone—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000988	0.00101	CcSEcCtD
Oxymorphone—Shock—Epirubicin—urinary bladder cancer	0.000975	0.000997	CcSEcCtD
Oxymorphone—Convulsion—Doxorubicin—urinary bladder cancer	0.000974	0.000996	CcSEcCtD
Oxymorphone—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000972	0.000994	CcSEcCtD
Oxymorphone—Hypertension—Doxorubicin—urinary bladder cancer	0.00097	0.000992	CcSEcCtD
Oxymorphone—Tachycardia—Epirubicin—urinary bladder cancer	0.000967	0.000989	CcSEcCtD
Oxymorphone—Skin disorder—Epirubicin—urinary bladder cancer	0.000963	0.000984	CcSEcCtD
Oxymorphone—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000958	0.00098	CcSEcCtD
Oxymorphone—Insomnia—Methotrexate—urinary bladder cancer	0.000958	0.00098	CcSEcCtD
Oxymorphone—Chest pain—Doxorubicin—urinary bladder cancer	0.000957	0.000978	CcSEcCtD
Oxymorphone—Anxiety—Doxorubicin—urinary bladder cancer	0.000953	0.000975	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.00095	0.000972	CcSEcCtD
Oxymorphone—Anorexia—Epirubicin—urinary bladder cancer	0.000945	0.000966	CcSEcCtD
Oxymorphone—Dyspnoea—Methotrexate—urinary bladder cancer	0.000944	0.000966	CcSEcCtD
Oxymorphone—Somnolence—Methotrexate—urinary bladder cancer	0.000941	0.000963	CcSEcCtD
Oxymorphone—Dry mouth—Doxorubicin—urinary bladder cancer	0.000936	0.000957	CcSEcCtD
Oxymorphone—Dyspepsia—Methotrexate—urinary bladder cancer	0.000932	0.000953	CcSEcCtD
Oxymorphone—Hypotension—Epirubicin—urinary bladder cancer	0.000926	0.000947	CcSEcCtD
Oxymorphone—Confusional state—Doxorubicin—urinary bladder cancer	0.000925	0.000946	CcSEcCtD
Oxymorphone—Decreased appetite—Methotrexate—urinary bladder cancer	0.000921	0.000941	CcSEcCtD
Oxymorphone—Oedema—Doxorubicin—urinary bladder cancer	0.000917	0.000938	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000914	0.000935	CcSEcCtD
Oxymorphone—Fatigue—Methotrexate—urinary bladder cancer	0.000913	0.000934	CcSEcCtD
Oxymorphone—Pain—Methotrexate—urinary bladder cancer	0.000906	0.000926	CcSEcCtD
Oxymorphone—Shock—Doxorubicin—urinary bladder cancer	0.000902	0.000923	CcSEcCtD
Oxymorphone—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000899	0.00092	CcSEcCtD
Oxymorphone—Insomnia—Epirubicin—urinary bladder cancer	0.000896	0.000917	CcSEcCtD
Oxymorphone—Tachycardia—Doxorubicin—urinary bladder cancer	0.000895	0.000915	CcSEcCtD
Oxymorphone—Skin disorder—Doxorubicin—urinary bladder cancer	0.000891	0.000911	CcSEcCtD
Oxymorphone—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000887	0.000907	CcSEcCtD
Oxymorphone—Dyspnoea—Epirubicin—urinary bladder cancer	0.000884	0.000904	CcSEcCtD
Oxymorphone—Somnolence—Epirubicin—urinary bladder cancer	0.000881	0.000901	CcSEcCtD
Oxymorphone—Anorexia—Doxorubicin—urinary bladder cancer	0.000874	0.000894	CcSEcCtD
Oxymorphone—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000873	0.000892	CcSEcCtD
Oxymorphone—Dyspepsia—Epirubicin—urinary bladder cancer	0.000872	0.000892	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000866	0.000886	CcSEcCtD
Oxymorphone—Decreased appetite—Epirubicin—urinary bladder cancer	0.000862	0.000881	CcSEcCtD
Oxymorphone—Hypotension—Doxorubicin—urinary bladder cancer	0.000857	0.000876	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000856	0.000875	CcSEcCtD
Oxymorphone—Fatigue—Epirubicin—urinary bladder cancer	0.000854	0.000874	CcSEcCtD
Oxymorphone—Pain—Epirubicin—urinary bladder cancer	0.000848	0.000867	CcSEcCtD
Oxymorphone—Constipation—Epirubicin—urinary bladder cancer	0.000848	0.000867	CcSEcCtD
Oxymorphone—Urticaria—Methotrexate—urinary bladder cancer	0.000841	0.00086	CcSEcCtD
Oxymorphone—Abdominal pain—Methotrexate—urinary bladder cancer	0.000837	0.000856	CcSEcCtD
Oxymorphone—Body temperature increased—Methotrexate—urinary bladder cancer	0.000837	0.000856	CcSEcCtD
Oxymorphone—Insomnia—Doxorubicin—urinary bladder cancer	0.000829	0.000848	CcSEcCtD
Oxymorphone—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000818	0.000836	CcSEcCtD
Oxymorphone—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000817	0.000835	CcSEcCtD
Oxymorphone—Somnolence—Doxorubicin—urinary bladder cancer	0.000815	0.000834	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.00081	0.000829	CcSEcCtD
Oxymorphone—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000807	0.000825	CcSEcCtD
Oxymorphone—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000797	0.000815	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000792	0.00081	CcSEcCtD
Oxymorphone—Fatigue—Doxorubicin—urinary bladder cancer	0.000791	0.000809	CcSEcCtD
Oxymorphone—Urticaria—Epirubicin—urinary bladder cancer	0.000787	0.000805	CcSEcCtD
Oxymorphone—Pain—Doxorubicin—urinary bladder cancer	0.000784	0.000802	CcSEcCtD
Oxymorphone—Constipation—Doxorubicin—urinary bladder cancer	0.000784	0.000802	CcSEcCtD
Oxymorphone—Abdominal pain—Epirubicin—urinary bladder cancer	0.000783	0.000801	CcSEcCtD
Oxymorphone—Body temperature increased—Epirubicin—urinary bladder cancer	0.000783	0.000801	CcSEcCtD
Oxymorphone—Hypersensitivity—Methotrexate—urinary bladder cancer	0.00078	0.000798	CcSEcCtD
Oxymorphone—Asthenia—Methotrexate—urinary bladder cancer	0.00076	0.000777	CcSEcCtD
Oxymorphone—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000756	0.000773	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.00075	0.000767	CcSEcCtD
Oxymorphone—Pruritus—Methotrexate—urinary bladder cancer	0.000749	0.000766	CcSEcCtD
Oxymorphone—Hypersensitivity—Epirubicin—urinary bladder cancer	0.00073	0.000747	CcSEcCtD
Oxymorphone—Urticaria—Doxorubicin—urinary bladder cancer	0.000729	0.000745	CcSEcCtD
Oxymorphone—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000725	0.000741	CcSEcCtD
Oxymorphone—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000725	0.000741	CcSEcCtD
Oxymorphone—Diarrhoea—Methotrexate—urinary bladder cancer	0.000725	0.000741	CcSEcCtD
Oxymorphone—Asthenia—Epirubicin—urinary bladder cancer	0.000711	0.000727	CcSEcCtD
Oxymorphone—Pruritus—Epirubicin—urinary bladder cancer	0.000701	0.000717	CcSEcCtD
Oxymorphone—Dizziness—Methotrexate—urinary bladder cancer	0.0007	0.000716	CcSEcCtD
Oxymorphone—Diarrhoea—Epirubicin—urinary bladder cancer	0.000678	0.000693	CcSEcCtD
Oxymorphone—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000676	0.000691	CcSEcCtD
Oxymorphone—Vomiting—Methotrexate—urinary bladder cancer	0.000673	0.000689	CcSEcCtD
Oxymorphone—Dermatitis—Methotrexate—urinary bladder cancer	0.000667	0.000682	CcSEcCtD
Oxymorphone—Headache—Methotrexate—urinary bladder cancer	0.000663	0.000678	CcSEcCtD
Oxymorphone—Asthenia—Doxorubicin—urinary bladder cancer	0.000658	0.000673	CcSEcCtD
Oxymorphone—Dizziness—Epirubicin—urinary bladder cancer	0.000655	0.00067	CcSEcCtD
Oxymorphone—Pruritus—Doxorubicin—urinary bladder cancer	0.000649	0.000663	CcSEcCtD
Oxymorphone—Vomiting—Epirubicin—urinary bladder cancer	0.00063	0.000644	CcSEcCtD
Oxymorphone—Nausea—Methotrexate—urinary bladder cancer	0.000629	0.000643	CcSEcCtD
Oxymorphone—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000627	0.000642	CcSEcCtD
Oxymorphone—Dermatitis—Epirubicin—urinary bladder cancer	0.000624	0.000638	CcSEcCtD
Oxymorphone—Headache—Epirubicin—urinary bladder cancer	0.000621	0.000635	CcSEcCtD
Oxymorphone—Dizziness—Doxorubicin—urinary bladder cancer	0.000606	0.00062	CcSEcCtD
Oxymorphone—Nausea—Epirubicin—urinary bladder cancer	0.000589	0.000602	CcSEcCtD
Oxymorphone—Vomiting—Doxorubicin—urinary bladder cancer	0.000583	0.000596	CcSEcCtD
Oxymorphone—Dermatitis—Doxorubicin—urinary bladder cancer	0.000578	0.000591	CcSEcCtD
Oxymorphone—Headache—Doxorubicin—urinary bladder cancer	0.000574	0.000587	CcSEcCtD
Oxymorphone—Nausea—Doxorubicin—urinary bladder cancer	0.000545	0.000557	CcSEcCtD
